Suppr超能文献

基于观察的早期预警评分用于检测即将发生的危重症,可预测接受异基因干细胞移植患者的院内生存率和总生存率。

Observation-based early warning scores to detect impending critical illness predict in-hospital and overall survival in patients undergoing allogeneic stem cell transplantation.

作者信息

von Lilienfeld-Toal Marie, Midgley Kirsten, Lieberbach Suzanne, Barnard Lorna, Glasmacher Axel, Gilleece Maria, Cook Gordon

机构信息

BMTU, St. James's University Hospital, Leeds, United Kingdom.

出版信息

Biol Blood Marrow Transplant. 2007 May;13(5):568-76. doi: 10.1016/j.bbmt.2006.12.455.

Abstract

Observation-based early warning scoring systems (EWSS) have been developed to improve the outcome of critically ill patients by triggering early critical care intervention. To date, none of these scoring systems have been evaluated in cancer patients or stem cell transplant (SCT) recipients. The aim of this study was to validate 3 established EWSS (modified early warning score [MEWS], patient-at-risk score [PARS], and Leed's early warning score [LEWS]) in adult recipients of Allogeneic SCT (Allo-SCT) and to determine their usefulness at predicting survival. We retrospectively analyzed the physiologic observations during the initial admission of 43 Allo-SCT recipients. Respiratory dysfunction was the most common (40 patients, 93%) event. All 3 EWSS revealed high accuracy in predicting in-hospital survival. The cutoff level associated with a high risk of in-hospital mortality was 7. Of 8 patients with a LEWS = 7, 6 died during their initial admission, whereas no patient with a lower score died (specificity 95%, sensitivity 100%). Acute clinical deterioration during the initial admission appeared to have an adverse effect on overall survival: in-hospital survivors with a LEWS >3 during their admission had a shorter median survival than patients with LEWS < or = 3, P = .018. This is the first study to validate EWSS in Allo-SCT and demonstrate that these systems are highly predictive of in-hospital and overall survival.

摘要

基于观察的早期预警评分系统(EWSS)已被开发出来,旨在通过触发早期重症监护干预来改善重症患者的治疗结果。迄今为止,这些评分系统均未在癌症患者或干细胞移植(SCT)受者中进行评估。本研究的目的是验证3种已确立的EWSS(改良早期预警评分[MEWS]、高危患者评分[PARS]和利兹早期预警评分[LEWS])在异基因SCT(Allo-SCT)成年受者中的有效性,并确定它们在预测生存方面的实用性。我们回顾性分析了43例Allo-SCT受者初次入院时的生理观察结果。呼吸功能障碍是最常见的事件(40例患者,93%)。所有3种EWSS在预测院内生存方面均显示出高准确性。与院内死亡高风险相关的临界值为7。在8例LEWS = 7的患者中,6例在初次入院期间死亡,而评分较低的患者无一死亡(特异性95%,敏感性100%)。初次入院期间的急性临床恶化似乎对总体生存有不利影响:入院时LEWS >3的院内幸存者的中位生存期短于LEWS≤3的患者,P = 0.018。这是第一项在Allo-SCT中验证EWSS的研究,并证明这些系统对院内生存和总体生存具有高度预测性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验